HIV-1 Infection, Injecting Drug Use, and Neuroendocrine Response to Psychological Stress

Area of Science:

• Neuroendocrinology
• Autonomic Nervous System (ANS) Research
• HIV/AIDS Pathophysiology

Background:

• HIV-1 infection is linked to neuroendocrine abnormalities and altered autonomic nervous system (ANS) activity.
• Previous research indicates a blunted norepinephrine (NE) response to stress in individuals with HIV-1.
• These ANS alterations may contribute to cognitive dysfunction observed in HIV-related conditions.

Purpose of the Study:

• To investigate the neuroendocrine stress response, specifically norepinephrine (NE) and cortisol, in individuals with HIV-1.
• To compare stress responses among three groups: HIV-1 with injecting drug use (IDU) history, HIV-1 without IDU history, and uninfected controls.
• To assess the impact of HIV-1 infection and IDU history on the hypothalamic-pituitary-adrenal (HPA) axis and ANS activity.

Main Methods:

• A comparative study design involving three participant groups: HIV-1 with IDU history, HIV-1 without IDU history, and uninfected controls.
• Stress induction using the Stroop Color-Word Test, a validated neuropsychological stressor.
• Serial blood sampling for serum norepinephrine, epinephrine, and cortisol levels before and at multiple points after stress induction.

Main Results:

• Individuals with both HIV-1 infection and a history of IDU demonstrated a significantly amplified NE response to stress.
• This exaggerated NE response in the HIV-1 with IDU group did not return to baseline levels within 20 minutes post-stress.
• While epinephrine and cortisol responses showed similar trends, between-group differences did not reach statistical significance.

Conclusions:

• The combination of HIV infection and a history of IDU may result in an exaggerated and prolonged neuroendocrine stress response.
• This sustained elevation in stress hormones could have implications for cognitive and physical functioning in affected individuals.
• Stress management interventions may be crucial for individuals with HIV and a history of IDU to mitigate potential adverse health outcomes.